Max Healthcare Institute Ltd. (NSE: MAXHEALTH) is one of India’s leading hospital chains, known for its premium healthcare services and strong financial performance. Investors closely track the Max Healthcare share price due to its growth potential in the expanding healthcare sector.
In this comprehensive guide, we’ll analyze:
✔ Current Max Healthcare share price & trends
✔ Historical performance & key financials
✔ Expert forecasts for 2025-2026
✔ Should you buy, hold, or sell?
✔ Competitor comparison & investment risks
1. Current Max Healthcare Share Price (June 2025)
As of June 13, 2025, the Max Healthcare share price closed at ₹1,232.80, up 2.55% from the previous close of ₹1,202.20 16.
Key Market Data:
-
52-Week High/Low: ₹1,239.50 / ₹836.60
-
Market Cap: ₹1.19 Trillion
-
P/E Ratio (TTM): 111.36 (High)
-
Dividend Yield: 0.12%
-
Volume (NSE): 2.93M shares
2. Historical Performance of Max Healthcare Stock
Max Healthcare has delivered strong returns over the years:
-
1-Year Return: +38.75%
-
3-Year Return: +251.52%
-
5-Year Return: +1,058.10% 6
Key Financial Highlights (FY 2025):
| Metric | Value |
|---|---|
| Revenue | ₹7,028 Cr (+30% YoY) |
| Net Profit | ₹1,076 Cr (+7% YoY) |
| EPS (TTM) | ₹11.07 |
| Debt-to-Equity | 0.32 |
3. Max Healthcare Share Price Forecast (2025-2026)
Analysts remain bullish on Max Healthcare due to expansion plans and rising healthcare demand.
Price Targets by Top Brokerages:
| Brokerage | Target Price | Recommendation |
|---|---|---|
| Motilal Oswal | ₹1,240 | Buy |
| UBS | ₹1,400 | Strong Buy |
| Axis Securities | ₹1,315 | Hold |
Long-Term Forecast:
-
2025 (Year-End): ₹1,300 – ₹1,450
-
2026 (Potential High): ₹1,500+ 211
4. Should You Invest in Max Healthcare?
Pros:
✅ Strong revenue & profit growth (30% CAGR)
✅ Expanding hospital network (17+ facilities)
✅ High institutional investor interest (FIIs hold 54.74%)
Cons:
❌ High valuation (P/E of 111)
❌ Low dividend yield (0.12%)
❌ Rising debt levels
Verdict: A long-term growth stock but may be overvalued for short-term traders.
5. Max Healthcare vs Competitors
| Stock | Share Price | P/E Ratio | Market Cap |
|---|---|---|---|
| Max Healthcare | ₹1,232.80 | 111.36 | ₹1.19T |
| Apollo Hospitals | ₹6,978.75 | 69.58 | ₹1.00T |
| Fortis Healthcare | ₹754.50 | 67.79 | ₹56,961 Cr |
Max Healthcare trades at a premium valuation compared to peers due to higher growth expectations 8.
6. Key Risks & Challenges
-
Regulatory changes in healthcare policies
-
Competition from Apollo, Fortis, and Narayana
-
High debt could impact profitability
7. Conclusion: Buy, Hold, or Sell?
-
Buy: If you believe in long-term healthcare growth.
-
Hold: If already invested, wait for further upside.
-
Sell: If looking for short-term gains, consider profit booking.
